Dunbar Geoffrey C
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Dunbar Geoffrey C. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| GYRE | SVP, Clin. Dev. & Reg. Affairs | Sale | 2,100 | $26.08 | $54,768 | Dec 17, 2010 |
| GYRE | SVP, Clin. Dev. & Reg. Affairs | Sale | 200 | $25.15 | $5,030 | Dec 16, 2010 |
| GYRE | SVP, Clin. Dev. & Reg. Affairs | Sale | 11,250 | $22.68 | $255,150 | Dec 8, 2010 |
| GYRE | SVP, Clin. Dev. & Reg. Affairs | Sale | 700 | $25.02 | $17,514 | Nov 5, 2010 |
| GYRE | SVP, Clin. Dev. & Reg. Affairs | Sale | 7,784 | $25.07 | $195,145 | Nov 3, 2010 |
| GYRE | SVP, Clin. Dev. & Reg. Affairs | Option Exercise | 1,494 | $1.75 | $2,615 | May 13, 2010 |
| GYRE | SVP, Clin. Dev. & Reg. Affairs | Sale | 14,700 | $24.00 | $352,800 | Apr 28, 2010 |
| GYRE | SVP, Clin. Dev. & Reg. Affairs | Option Exercise | 200 | $1.75 | $350 | Apr 26, 2010 |
| GYRE | VP, Clin. Dev. & Reg. Affairs | Sale | 22,602 | $21.86 | $494,080 | Dec 16, 2009 |
| GYRE | VP, Clin. Dev. & Reg. Affairs | Option Exercise | 11,000 | $1.75 | $19,250 | Sep 18, 2009 |
| GYRE | VP, Clin. Dev. & Reg. Affairs | Sale | 9,050 | $16.27 | $147,244 | Sep 16, 2009 |
| GYRE | VP, Clin. Dev. & Reg. Affairs | Sale | 10,000 | $15.02 | $150,200 | Sep 4, 2009 |
| GYRE | VP, Clin. Dev. & Reg. Affairs | Sale | 2,100 | $14.00 | $29,400 | Aug 28, 2009 |
| GYRE | VP, Clin. Dev. & Reg. Affairs | Sale | 1,281 | $10.00 | $12,810 | Aug 15, 2008 |
| GYRE | VP, Clin. Dev. & Reg. Affairs | Sale | 1,473 | $10.00 | $14,730 | Aug 13, 2008 |
| GYRE | VP, Clin. Dev. & Reg. Affairs | Sale | 5,000 | $9.02 | $45,100 | Jul 30, 2008 |
| GYRE | VP Clin. Dev. & Reg. Affairs | Option Exercise | 11,856 | $1.75 | $20,748 | Nov 6, 2006 |